Conclusion
Intravenous Nicorandil could significantly reduce systolic and diastolic blood pressure in patients without affecting heart rate, and it reduced in depending on concentrations, suggesting that Intravenous Nicorandil may be a new intravenous antihypertensive drug in future clinical application.